Medical technology company BD (Becton, Dickinson and Company) announced on Monday that it has launched its first high-throughput, robotics-compatible reagent kit aimed at automating large-scale, single-cell discovery studies.

By integrating Hamilton's robotics with BD's reagent kits, this solution enhances workflow efficiency, minimizes human error and accelerates research in fields like oncology and immunology. The collaboration also standardizes manual processes and speeds up the generation of material for genetic sequencing.

Featuring BD's OMICS-One XT WTA Assay and Hamilton's Microlab NGS STAR platform, the automated solution allows for seamless integration into existing laboratory workflows. Researchers worldwide can now improve consistency and throughput in genomics applications. Traditional manual DNA library construction, previously time-consuming and prone to variability, is now streamlined, reducing costs and turnaround times.